Kechow Pharma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 80

Employees

  • Latest Deal Type
  • Series D

  • Financing Rounds
  • 8

Kechow Pharma General Information

Description

Researcher and developer of targeted drugs designed for tumor therapy. The company focuses on the R&D and production of new anti-cancerous drugs with specialized drug development team from discovery, clinical development to registration, enabling patients providing high-quality oncology drugs to meet clinical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Block M, Floor 3, No. 780 Cailun Road
  • Zhangjiang Hi-Tech Park, Pudong New Area
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Block M, Floor 3, No. 780 Cailun Road
  • Zhangjiang Hi-Tech Park, Pudong New Area
  • Shanghai, 201203
  • China
+86 021

Kechow Pharma Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kechow Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kechow Pharma‘s full profile, request access.

Request a free trial

Kechow Pharma Patents

Kechow Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240300980-A1 Heterocyclic compounds as kras inhibitor, and preparation therefor and use thereof in treatment Pending 22-May-2021
CA-3203080-A1 Preparation and application method of heterocyclic compound as kras inhibitor Pending 22-Dec-2020
AU-2021407653-A1 Preparation and application method of heterocyclic compound as kras inhibitor Pending 22-Dec-2020
EP-4269405-A1 Preparation and application method of heterocyclic compound as kras inhibitor Pending 22-Dec-2020
US-20240109893-A1 Preparation and application method of heterocyclic compounds as kras inhibitor Pending 22-Dec-2020 C07D487/02
To view Kechow Pharma’s complete patent history, request access »

Kechow Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kechow Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kechow Pharma‘s full profile, request access.

Request a free trial

Kechow Pharma FAQs

  • When was Kechow Pharma founded?

    Kechow Pharma was founded in 2014.

  • Where is Kechow Pharma headquartered?

    Kechow Pharma is headquartered in Shanghai, China.

  • What is the size of Kechow Pharma?

    Kechow Pharma has 80 total employees.

  • What industry is Kechow Pharma in?

    Kechow Pharma’s primary industry is Drug Discovery.

  • Is Kechow Pharma a private or public company?

    Kechow Pharma is a Private company.

  • What is the current valuation of Kechow Pharma?

    The current valuation of Kechow Pharma is .

  • What is Kechow Pharma’s current revenue?

    The current revenue for Kechow Pharma is .

  • How much funding has Kechow Pharma raised over time?

    Kechow Pharma has raised $63M.

  • Who are Kechow Pharma’s investors?

    Detong Capital, Hangzhou Hongcheng Capital, Hubei High-tech Industrial Investment Group, Infinity Group, and JHT Asset Management are 5 of 22 investors who have invested in Kechow Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »